FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Kudo, E
   Israelow, B
   Vogels, CBF
   Lu, PW
   Wyllie, AL
   Tokuyama, M
   Venkataraman, A
   Brackney, DE
   Ott, IM
   Petrone, ME
   Earnest, R
   Lapidus, S
   Muenker, MC
   Moore, AJ
   Casanovas-Massana, A
   Omer, SB
   Dela Cruz, CS
   Farhadian, SF
   Ko, ALI
   Grubaugh, ND
   Iwasaki, A
AF Kudo, Eriko
   Israelow, Benjamin
   Vogels, Chantal B. F.
   Lu, Peiwen
   Wyllie, Anne L.
   Tokuyama, Maria
   Venkataraman, Arvind
   Brackney, Doug E.
   Ott, Isabel M.
   Petrone, Mary E.
   Earnest, Rebecca
   Lapidus, Sarah
   Muenker, M. Catherine
   Moore, Adam J.
   Casanovas-Massana, Arnau
   Omer, Saad B.
   Dela Cruz, Charles S.
   Farhadian, Shelli F.
   Ko, Albert I.
   Grubaugh, Nathan D.
   Iwasaki, Akiko
TI Detection of SARS-CoV-2 RNA by multiplex RT-qPCR
SO PLOS BIOLOGY
LA English
DT Article
AB The current quantitative reverse transcription PCR (RT-qPCR) assay recommended for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing in the United States requires analysis of 3 genomic targets per sample: 2 viral and 1 host. To simplify testing and reduce the volume of required reagents, we devised a multiplex RT-qPCR assay to detect SARS-CoV-2 in a single reaction. We used existing N1, N2, and RP primer and probe sets by the Centers for Disease Control and Prevention, but substituted fluorophores to allow multiplexing of the assay. The cycle threshold (Ct) values of our multiplex RT-qPCR were comparable to those obtained by the single assay adapted for research purposes. Low copy numbers (>= 500 copies/reaction) of SARS-CoV-2 RNA were consistently detected by the multiplex RT-qPCR. Our novel multiplex RT-qPCR improves upon current single diagnostics by saving reagents, costs, time, and labor.
C1 [Kudo, Eriko; Israelow, Benjamin; Lu, Peiwen; Tokuyama, Maria; Iwasaki, Akiko] Yale Sch Med, Dept Immunobiol, New Haven, CT 06510 USA.
   [Israelow, Benjamin; Omer, Saad B.; Farhadian, Shelli F.] Yale Sch Med, Infect Dis Sect, Dept Internal Med, New Haven, CT USA.
   [Vogels, Chantal B. F.; Wyllie, Anne L.; Brackney, Doug E.; Ott, Isabel M.; Petrone, Mary E.; Earnest, Rebecca; Lapidus, Sarah; Muenker, M. Catherine; Moore, Adam J.; Casanovas-Massana, Arnau; Omer, Saad B.; Ko, Albert I.; Grubaugh, Nathan D.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
   [Venkataraman, Arvind; Omer, Saad B.] Yale Inst Global Hlth, New Haven, CT USA.
   [Omer, Saad B.] Yale Sch Nursing, New Haven, CT USA.
   [Dela Cruz, Charles S.] Yale Sch Med, Dept Internal Med, Sect Pulm Crit Care & Sleep Med, New Haven, CT USA.
   [Iwasaki, Akiko] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
RP Iwasaki, A (corresponding author), Yale Sch Med, Dept Immunobiol, New Haven, CT 06510 USA.; Grubaugh, ND (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.; Iwasaki, A (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
EM nathan.grubaugh@yale.edu; akiko.iwasaki@yale.edu
OI Israelow, Benjamin/0000-0002-1308-8246; Vogels,
   Chantal/0000-0003-0027-6480; Muenker, M. Catherine/0000-0002-0450-0868
FU Women's Health Research at Yale Pilot Project Program; Fast Grant from
   Emergent Ventures at the Mercatus Center; Mathers Foundation; Beatrice
   Kleinberg Neuwirth Fund; Yale Institute for Global Health; Ludwig Family
   Foundation; NIAIDUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI127429, R01AI157488,
   2T32AI007517-16]; Japan Society for the Promotion of ScienceMinistry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan
   Society for the Promotion of Science
FX Research was supported in part by the Women's Health Research at Yale
   Pilot Project Program (A.I.), Fast Grant from Emergent Ventures at the
   Mercatus Center (A.I.), Mathers Foundation (A.I.), the Beatrice
   Kleinberg Neuwirth Fund (A.I.), Yale Institute for Global Health
   (N.D.G.), the Ludwig Family Foundation (A.I.), and NIAID R01AI127429
   (A.I.), R01AI157488 (A.I., S.F.), 2T32AI007517-16 (to BI), the Japan
   Society for the Promotion of Science (to EK), A.I. is an Investigator of
   the Howard Hughes Medical Institute. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Chu DKW, 2020, CLIN CHEM, V66, P549, DOI 10.1093/clinchem/hvaa029
   Corman VM, 2019, EUROSURVEILLANCE, V2020, P25, DOI DOI 10.2807/1560-7917.ES.202025.3.2000045
   Harcourt Jennifer, 2020, bioRxiv, DOI 10.1101/2020.03.02.972935
   National Institute For viral Disease Control and prevention of PRC, 2020, SPEC PRIM PROB DET 2
   Singanayagam A, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.32.2001483
   US Centers for Disease Control and Prevention, 2020, 2019 NOV COR 2019 NC
   Vogels CBF, 2020, NAT MICROBIOL, V5, P1299, DOI 10.1038/s41564-020-0761-6
   WHO Novel Coronavirus, 2020, 101 WHO
   Wyllie AL, 2020, NEW ENGL J MED, V383, P1283, DOI 10.1056/NEJMc2016359
NR 9
TC 0
Z9 0
U1 3
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1544-9173
EI 1545-7885
J9 PLOS BIOL
JI PLoS. Biol.
PD OCT
PY 2020
VL 18
IS 10
AR e3000867
DI 10.1371/journal.pbio.3000867
PG 9
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA OF9BM
UT WOS:000581493400001
PM 33027248
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Chui, CHK
   Ko, A
AF Chui, Cheryl Hiu-Kwan
   Ko, Albert
TI Converging humanitarian technology and social work in a public health
   crisis: a social innovation response to COVID-19 in Hong Kong
SO ASIA PACIFIC JOURNAL OF SOCIAL WORK AND DEVELOPMENT
LA English
DT Article; Early Access
DE Humanitarian technology; social innovation; vulnerable population;
   asset-based community development
ID MANAGEMENT; POLICY
AB Public health crises disproportionately affect vulnerable population groups. Interventions aimed at curtailing the spread of diseases or improving the overall health of the population must aim to reduce existing inequalities rather than exacerbate them. Drawing on social innovation and asset-based community development literature, this article describes the design principles of a project utilising humanitarian technology for disinfectant and sanitation purposes in light of the COVID-19 pandemic. It provides insights into the merits of cross-sector collaboration, particularly between social work and engineering, in effectively addressing the health and sanitation needs of low-income families living in subdivided units in Hong Kong. The project underscores the potential of social innovation in addressing the needs of the vulnerable communities in public health crises.
C1 [Chui, Cheryl Hiu-Kwan] Univ Hong Kong, Dept Social Work & Social Adm, Pok Fu Lam, Hong Kong, Peoples R China.
   [Ko, Albert] Lingnan Univ, Hong Kong, Peoples R China.
RP Chui, CHK (corresponding author), Univ Hong Kong, Dept Social Work & Social Adm, Pok Fu Lam, Hong Kong, Peoples R China.
EM chkchui@hku.hk
OI Chui, Cheryl Hiu-kwan/0000-0002-3284-5724
FU Hong Kong Jockey Club Charities Trust
FX This work was supported by the Hong Kong Jockey Club Charities Trust.
CR AGOSTINI MANUELA RÖSING, 2016, RAM, Rev. Adm. Mackenzie, V17, P72, DOI 10.1590/1678-69712016/administracao.v17n6p72-101
   Andries P, 2019, RES POLICY, V48, P281, DOI 10.1016/j.respol.2018.08.017
   Bahar OS, 2017, RES SOCIAL WORK PRAC, V27, P131, DOI 10.1177/1049731516658769
   Bent-Goodley TB, 2014, SOC WORK, V59, P101, DOI 10.1093/sw/swu006
   Blickem C, 2018, SAGE OPEN, V8, DOI 10.1177/2158244018787223
   Braveman P, 2014, PUBLIC HEALTH REP, V129, P5, DOI 10.1177/00333549141291S203
   Chui C, 2014, INT J DISAST RISK RE, V10, P28, DOI 10.1016/j.ijdrr.2014.07.001
   Chui CHK, 2020, J APPL GERONTOL, V39, P463, DOI 10.1177/0733464819873504
   Chui CHK, 2020, J APPL GERONTOL, V39, P1008, DOI 10.1177/0733464819838448
   Flynn ML, 2017, RES SOCIAL WORK PRAC, V27, P123, DOI 10.1177/1049731516686198
   Golightley M, 2020, BRIT J SOC WORK, V50, P637, DOI 10.1093/bjsw/bcaa036
   Golightley M, 2019, BRIT J SOC WORK, V49, P1373, DOI 10.1093/bjsw/bcz105
   Grimm R, 2013, INNOVATION-ABINGDON, V26, P436, DOI 10.1080/13511610.2013.848163
   Holliday I, 2000, POLIT STUD-LONDON, V48, P706, DOI 10.1111/1467-9248.00279
   Ika LA, 2017, INT J PROJ MANAG, V35, P44, DOI 10.1016/j.ijproman.2016.10.005
   Ika LA, 2012, PROJ MANAG J, V43, P27, DOI 10.1002/pmj.21281
   Lau PYF, 2012, POVERTY PUBLIC POLIC, V4, P35, DOI 10.1002/pop4.3
   Legislative Council Secretariat, 2018, SUBD UN HONG KONG
   Lorenc T, 2013, J EPIDEMIOL COMMUN H, V67, P190, DOI 10.1136/jech-2012-201257
   Miller VJ, 2020, J GERONTOL SOC WORK, DOI 10.1080/01634372.2020.1769792
   Phills JA, 2008, STANFORD SOC INNOVAT, V6, P34, DOI DOI 10.1111/J.1369-7625.2010.00656.X
   Putnam R.D., 2000, CULTURE AND POLITICS
   Shek DTL, 2004, J GENET PSYCHOL, V165, P272, DOI 10.3200/GNTP.165.3.272-292
   Sherraden M, 1991, ASSETS POOR NEW AM W
   Stevens MR, 2010, ENVIRON MANAGE, V45, P320, DOI 10.1007/s00267-009-9397-2
   The Census and Statistics Department of Hong Kong, 2017, THEM REP HOUS INC DI
   United Nations, 2020, COVID 19 RESP CIV SO
   van de Venter E, 2016, LANCET, V388, P108
   Vickers I, 2017, RES POLICY, V46, P1755, DOI 10.1016/j.respol.2017.08.003
   Walter-McCabe HA, 2020, SOC WORK PUBLIC HLTH, V35, P69, DOI 10.1080/19371918.2020.1751533
   Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548
NR 31
TC 0
Z9 0
U1 12
U2 12
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0218-5385
EI 2165-0993
J9 ASIA PAC J SOC WORK
JI Asia Pac. J. Soc. Work Dev.
DI 10.1080/02185385.2020.1790412
EA JUL 2020
PG 8
WC Social Work
SC Social Work
GA MI4ZL
UT WOS:000547417900001
OA Bronze
DA 2020-11-30
ER

PT J
AU Lebov, JF
   Arias, JF
   Balmaseda, A
   Britt, W
   Cordero, JF
   Galvao, LA
   Garces, AL
   Hambidge, KM
   Harris, E
   Ko, A
   Krebs, N
   Marques, ETA
   Martinez, AM
   McClure, E
   Miranda, DB
   Moreira, MEL
   Mussi-Pinhata, MM
   Ochoa, TJ
   Osorio, JE
   Scalabrin, DMF
   Schultz-Cherry, S
   Seage, GR
   Stolka, K
   Ugarte-Gil, CA
   Vega, CMV
   Welton, M
   Ximenes, R
   Zorrilla, C
AF Lebov, Jill F.
   Arias, Juan F.
   Balmaseda, Angel
   Britt, William
   Cordero, Jose F.
   Galvao, Luiz Augusto
   Lucia Garces, Ana
   Hambidge, K. Michael
   Harris, Eva
   Ko, Albert
   Krebs, Nancy
   Marques, Ernesto T. A.
   Martinez, Alexander M.
   McClure, Elizabeth
   Miranda-Filho, Democrito B.
   Lopes Moreira, Maria Elisabeth
   Mussi-Pinhata, Marisa M.
   Ochoa, Theresa J.
   Osorio, Jorge E.
   Scalabrin, Deolinda M. F.
   Schultz-Cherry, Stacey
   Seage, George R., III
   Stolka, Kristen
   Augusto Ugarte-Gil, Cesar
   Vega, Carmen Milagros Velez
   Welton, Michael
   Ximenes, Ricardo
   Zorrilla, Carmen
TI International prospective observational cohort study of Zika in infants
   and pregnancy (ZIP study): study protocol (vol 19, 282, 2019)
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Correction
C1 [Lebov, Jill F.; McClure, Elizabeth; Stolka, Kristen] RTI Int, Social Stat & Environm Sci, Durham, NC 27709 USA.
   [Arias, Juan F.; Schultz-Cherry, Stacey] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.
   [Balmaseda, Angel] Complejo Nacl Salud, Ctr Nacl Diagnost & Referencia, Managua, Nicaragua.
   [Britt, William] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA.
   [Cordero, Jose F.; Welton, Michael] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA.
   [Galvao, Luiz Augusto] Fiocruz MS, Ctr Global Hlth CRIS, Rio De Janeiro, Brazil.
   [Lucia Garces, Ana] Ctr Amer & Panama INCAP, Fdn Alimentac & Nutr, Guatemala City, Guatemala.
   [Hambidge, K. Michael; Krebs, Nancy] Univ Colorado, Sect Nutr, Pediat, Aurora, CO USA.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Ko, Albert; Scalabrin, Deolinda M. F.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Ko, Albert; Scalabrin, Deolinda M. F.] Fundacao Oswaldo Cruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Sch Publ Hlth, Pittsburgh, PA 15260 USA.
   [Marques, Ernesto T. A.] Fiocruz MS, Dept Virol & Expt Therapeut, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Martinez, Alexander M.] Imbanaco Med Ctr, Res Inst, Cali, Colombia.
   [Miranda-Filho, Democrito B.] Univ Pernambuco, Microcephaly Epidem Res Grp, PPGCS, Recife, PE, Brazil.
   [Lopes Moreira, Maria Elisabeth] Fiocruz MS, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
   [Mussi-Pinhata, Marisa M.] Ribeirao Preto Med Sch, Ribeirao Preto, Brazil.
   [Ochoa, Theresa J.; Augusto Ugarte-Gil, Cesar] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru.
   [Ochoa, Theresa J.; Augusto Ugarte-Gil, Cesar] Univ Peruana Cayetano Heredia, Fac Med, Lima, Peru.
   [Osorio, Jorge E.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [Seage, George R., III] Harvard Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   [Vega, Carmen Milagros Velez] Univ Puerto Rico, San Juan, PR 00936 USA.
   [Ximenes, Ricardo] Univ Fed Pernambuco, Microcephaly Epidem Res Grp, Dept Med Trop, Recife, PE, Brazil.
   [Zorrilla, Carmen] Maternal Infant Studies Ctr CEMI, San Juan, PR USA.
RP Lebov, JF (corresponding author), RTI Int, Social Stat & Environm Sci, Durham, NC 27709 USA.
EM jlebov@rti.org
RI Ugarte-Gil, Cesar/E-6074-2013; Marques, Ernesto T. A/L-4967-2013
OI Ugarte-Gil, Cesar/0000-0002-2833-9087; Marques, Ernesto T.
   A/0000-0003-3826-9358; Galvao, Luiz Augusto/0000-0002-3918-0286;
   McClure, Elizabeth/0000-0001-8659-5444
FU NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Mental Health (NIMH) [R25MH083617, R25MH083617,
   R25MH083617] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Mental Health (NIMH) [R25 MH083617]
   Funding Source: Medline
CR Lebov JF, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2430-4
NR 1
TC 1
Z9 1
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD NOV 19
PY 2019
VL 19
IS 1
AR 423
DI 10.1186/s12884-019-2589-8
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA KE3OE
UT WOS:000508467800004
PM 31744466
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Ko, A
   Reni, M
   Riess, H
   Pelzer, U
   O'Reilly, EM
   Winter, J
   Oh, DY
   Li, CP
   Tortora, G
   Chang, HM
   Lopez, CD
   Tabernero, J
   Van Cutsem, E
   Philip, P
   Goldstein, D
   Berlin, JD
   Ferrara, S
   Li, M
   Lu, B
   Romano, A
   Marks, H
   Biankin, A
   Tempero, MA
AF Ko, A.
   Reni, M.
   Riess, H.
   Pelzer, U.
   O'Reilly, E. M.
   Winter, J.
   Oh, D. Y.
   Li, C. P.
   Tortora, G.
   Chang, H. M.
   Lopez, C. D.
   Tabernero, J.
   Van Cutsem, E.
   Philip, P.
   Goldstein, D.
   Berlin, J. D.
   Ferrara, S.
   Li, M.
   Lu, B.
   Romano, A.
   Marks, H.
   Biankin, A.
   Tempero, M. A.
TI APACT: Phase III, Multicenter, International, Open-Label, Randomized
   Trial of Adjuvant nab-Paclitaxel Plus Gemcitabine (nab-P/G) Versus
   Gemcitabine (G) for Surgically Resected Pancreatic Adenocarcinoma
SO PANCREAS
LA English
DT Meeting Abstract
C1 [Ko, A.; Tempero, M. A.] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, Dept Hematol & Oncol, San Francisco, CA 94143 USA.
   [Reni, M.] IRCCS Osped San Raffaele, Oncol, Milan, Italy.
   [Riess, H.; Pelzer, U.] Charite Univ Med Berlin, Oncol & Hematol, Berlin, Germany.
   [Riess, H.; Pelzer, U.] Humboldt Univ, Freie Univ Berlin, Berlin, Germany.
   [Riess, H.; Pelzer, U.] Berlin Inst Hlth, Berlin, Germany.
   [O'Reilly, E. M.] Mem Sloan Kettering Canc Ctr, Med Oncol, 1275 York Ave, New York, NY 10021 USA.
   [Winter, J.] Thomas Jefferson Univ Hosp, Dept Surg, Philadelphia, PA 19107 USA.
   [Oh, D. Y.] Seoul Natl Univ, Coll Med, Canc Res Inst, Hemato Oncol,Seoul Natl Univ Hosp, Seoul, South Korea.
   [Li, C. P.] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan.
   [Tortora, G.] Azienda Osped Univ, Med Oncol, Verona, Italy.
   [Tortora, G.] Fdn Policlin Univ Gemelli, IRCCS, Med Oncol, Rome, Italy.
   [Chang, H. M.] Asan Med Ctr, Biliary & Pancreat Canc Ctr, Dept Oncol, Seoul, South Korea.
   [Lopez, C. D.] Oregon Hlth & Sci Univ, Dept Hematol Oncol, Portland, OR 97201 USA.
   [Tabernero, J.] Vall dHebron Univ Hosp, Dept Med Oncol, Barcelona, Spain.
   [Tabernero, J.] Vall dHebron Inst Oncol VHIO, Barcelona, Spain.
   [Van Cutsem, E.] Univ Hosp Gasthuisberg Leuven, Dept Digest Oncol, Leuven, Belgium.
   [Van Cutsem, E.] Katholieke Univ Leuven, Leuven, Belgium.
   [Philip, P.] Karmanos Canc Inst, Dept Gastrointestinal Oncol, Detroit, MI USA.
   [Goldstein, D.] Univ New South Wales, Prince Wales Hosp, Nelune Canc Ctr, Dept Med Oncol, Randwick, NSW, Australia.
   [Berlin, J. D.] Vanderbilt Ingram Canc Ctr, Dept Med Oncol, Nashville, TN USA.
   [Ferrara, S.; Li, M.; Lu, B.; Romano, A.; Marks, H.] Celgene Corp, Med Res & Dev, Summit, NJ USA.
   [Biankin, A.] Univ Glasgow, Dept Surg, Glasgow, Lanark, Scotland.
RI Pelzer, Uwe/AAX-1957-2020
OI Pelzer, Uwe/0000-0001-9213-2737
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0885-3177
EI 1536-4828
J9 PANCREAS
JI Pancreas
PD NOV-DEC
PY 2019
VL 48
IS 10
BP 1464
EP 1464
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA KA3QG
UT WOS:000505712800276
DA 2020-11-30
ER

PT J
AU Lee, BS
   Chang, K
   Nguyen, AK
   Tekeste, TF
   Girgis, A
   Adeyemo, M
   Hanna, MS
   Kwok, K
   Giap, AQ
   Chaya, C
   Hunt, GC
   Kao, K
   Attam, R
   Ko, A
   Yao, JF
   Pio, JR
   Tovar, S
   Lim, BS
AF Lee, Brian S.
   Chang, Karen
   Nguyen, Andrew K.
   Tekeste, Timnit F.
   Girgis, Agathon
   Adeyemo, Mopelola
   Hanna, Maryam S.
   Kwok, Karl
   Giap, Andrew Q.
   Chaya, Charles
   Hunt, Gordon C.
   Kao, Kevin
   Attam, Rajeev
   Ko, Albert
   Yao, Janis F.
   Pio, Jose R.
   Tovar, Stephanie
   Lim, Brian S.
TI Long-Term Follow-Up of Patients With Pancreatic Cystic Lesions Who Had
   No Significant Changes in the First 5 Years of Diagnosis
SO AMERICAN JOURNAL OF GASTROENTEROLOGY
LA English
DT Meeting Abstract
CT Annual Scientific Meeting of the American-College-of-Gastroenterology
   (ACG)
CY OCT 25-30, 2019
CL San Antonio, TX
SP Amer Coll Gastroenterol
C1 [Lee, Brian S.; Nguyen, Andrew K.; Adeyemo, Mopelola; Hanna, Maryam S.; Lim, Brian S.] Univ Calif Riverside, Sch Med, Riverside, CA 92521 USA.
   [Chang, Karen] Univ Calif Riverside, Sch Med, Moreno Valley, CA USA.
   [Tekeste, Timnit F.] Univ Calif Riverside, Sch Med, Corona, CA USA.
   [Girgis, Agathon] Kaiser Permanente Med Ctr, Walnut Creek, CA USA.
   [Kwok, Karl] Kaiser Permanente Los Angeles, Med Ctr, Los Angeles, CA USA.
   [Giap, Andrew Q.] Kaiser Permanente, Anaheim, CA USA.
   [Chaya, Charles; Ko, Albert] Kaiser Permanente, Riverside, CA USA.
   [Hunt, Gordon C.] Kaiser Permanente, San Diego, CA USA.
   [Kao, Kevin] Kaiser Permanente, Downey, CA USA.
   [Attam, Rajeev] Kaiser Permanente, SCPMG, Downey, CA USA.
   [Yao, Janis F.; Pio, Jose R.] Kaiser Permanente, Pasadena, CA USA.
   [Tovar, Stephanie] Southern Calif Permanente Med Grp, Santa Fe Springs, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0002-9270
EI 1572-0241
J9 AM J GASTROENTEROL
JI Am. J. Gastroenterol.
PD OCT
PY 2019
VL 114
SU S
MA 80
BP S48
EP S48
DI 10.14309/01.ajg.0000589852.45106.f5
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA KG2FF
UT WOS:000509756000081
OA Bronze
DA 2020-11-30
ER

PT J
AU Bujak, AZ
   Weng, CF
   Silva, MJ
   Yeung, M
   Lo, L
   Ftouni, S
   Litchfield, C
   Ko, A
   Kuykhoven, K
   van Geelen, C
   Chandrashekar, S
   Dawson, MA
   Loi, S
   Wong, SQ
   Dawson, SJ
AF Bujak, A. Z.
   Weng, C. -F.
   Silva, M. -J.
   Yeung, M.
   Lo, L.
   Ftouni, S.
   Litchfield, C.
   Ko, A.
   Kuykhoven, K.
   van Geelen, C.
   Chandrashekar, S.
   Dawson, M. A.
   Loi, S.
   Wong, S. Q.
   Dawson, S. -J.
TI Prospective testing of circulating tumour DNA in metastatic breast
   cancer facilitates clinical trial enrollment and precision oncology
SO ANNALS OF ONCOLOGY
LA English
DT Meeting Abstract
CT 44th Congress of the European-Society-for-Medical-Oncology (ESMO)
CY SEP 27-OCT 01, 2019
CL Barcelona, SPAIN
SP European Soc Med Oncol, Japanese Soc Med Oncol
C1 [Bujak, A. Z.; Weng, C. -F.; Silva, M. -J.; Yeung, M.; Lo, L.; Ftouni, S.; Litchfield, C.; Ko, A.; Kuykhoven, K.; van Geelen, C.; Chandrashekar, S.; Dawson, M. A.; Loi, S.; Wong, S. Q.; Dawson, S. -J.] Peter MacCallum Canc Ctr, Canc Res, Melbourne, Vic, Australia.
FU National Health and Medical Research Council AustraliaNational Health
   and Medical Research Council of Australia
FX National Health and Medical Research Council Australia.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0923-7534
EI 1569-8041
J9 ANN ONCOL
JI Ann. Oncol.
PD OCT
PY 2019
VL 30
SU 5
MA 105P
PG 1
WC Oncology
SC Oncology
GA JF3NY
UT WOS:000491295500318
DA 2020-11-30
ER

PT J
AU Nguyen, AK
   Girgis, A
   Tekeste, T
   Chang, K
   Adeyemo, M
   Eskandari, A
   Alonso, E
   Yaramada, P
   Chaya, C
   Ko, A
   Burke, E
   Roggow, I
   Butler, R
   Kawatkar, A
   Lim, BS
AF Nguyen, Andrew Khoi
   Girgis, Agathon
   Tekeste, Timnit
   Chang, Karen
   Adeyemo, Mopelola
   Eskandari, Armen
   Alonso, Emilio
   Yaramada, Priyanka
   Chaya, Charles
   Ko, Albert
   Burke, Edmund
   Roggow, Isaiah
   Butler, Rebecca
   Kawatkar, Aniket
   Lim, Brian S.
TI Effect of a region-wide incorporation of an algorithm based on the 2012
   international consensus guideline on the practice pattern for the
   management of pancreatic cystic neoplasms in an integrated health system
SO WORLD JOURNAL OF CLINICAL CASES
LA English
DT Article
DE Pancreatic cyst; Algorithm incorporation; Pancreas; Optimization of
   resource utilization; Fukuoka criteria; Sendai criteria; Pancreatic
   cancer; Intraductal papillary mucinous neoplasm; Practice management;
   Algorithm
ID PAPILLARY MUCINOUS NEOPLASM; DIAGNOSIS; IPMN
AB AIM
   To examine the practice pattern in Kaiser Permanente Southern California (KPSC), i.e., gastroenterology (GI)/surgery referrals and endoscopic ultrasound (EUS), for pancreatic cystic neoplasms (PCNs) after the region-wide dissemination of the PCN management algorithm.
   METHODS
   Retrospective review was performed; patients with PCN diagnosis given between April 2012 and April 2015 (18 mo before and after the publication of the algorithm) in KPSC (integrated health system with 15 hospitals and 202 medical offices in Southern California) were identified.
   RESULTS
   2558 (1157 pre- and 1401 post-algorithm) received a new diagnosis of PCN in the study period. There was no difference in the mean cyst size (pre- 19.1 mm vs post- 18.5 mm, P = 0.119). A smaller percentage of PCNs resulted in EUS after the implementation of the algorithm (pre- 45.5% vs post- 34.8%, P < 0.001). A smaller proportion of patients were referred for GI (pre- 65.2% vs post- 53.3%, P < 0.001) and surgery consultations (pre- 24.8% vs post- 16%, P < 0.001) for PCN after the implementation. There was no significant change in operations for PCNs. Cost of diagnostic care was reduced after the implementation by 24%, 18%, and 36% for EUS, GI, and surgery consultations, respectively, with total cost saving of 24%.
   CONCLUSION
   In the current healthcare climate, there is increased need to optimize resource utilization. Dissemination of an algorithm for PCN management in an integrated health system resulted in fewer EUS and GI/surgery referrals, likely by aiding the physicians ordering imaging studies in the decision making for the management of PCNs. This translated to cost saving of 24%, 18%, and 36% for EUS, GI, and surgical consultations, respectively, with total diagnostic cost saving of 24%.
C1 [Nguyen, Andrew Khoi; Girgis, Agathon; Tekeste, Timnit; Chang, Karen; Adeyemo, Mopelola; Eskandari, Armen; Alonso, Emilio; Yaramada, Priyanka; Roggow, Isaiah; Lim, Brian S.] Univ Calif Riverside, Sch Med, 900 Univ Ave, Riverside, CA 92521 USA.
   [Chaya, Charles; Lim, Brian S.] Kaiser Permanente, Riverside Med Ctr, Dept Gastroenterol, Riverside, CA 92521 USA.
   [Ko, Albert; Burke, Edmund] Kaiser Permanente, Riverside Med Ctr, Dept Surg, Riverside, CA 92521 USA.
   [Butler, Rebecca; Kawatkar, Aniket] Southern Calif Permanente Med Grp, Dept Res & Evaluat, Pasadena, CA 92521 USA.
RP Nguyen, AK (corresponding author), Univ Calif Riverside, Sch Med, 900 Univ Ave, Riverside, CA 92521 USA.
EM andrew.nguyen@medsch.uct.edu
CR Brugge WR, 2004, NEW ENGL J MED, V351, P1218, DOI 10.1056/NEJMra031623
   de Jong K, 2010, CLIN GASTROENTEROL H, V8, P806, DOI 10.1016/j.cgh.2010.05.017
   Farrell JJ, 2013, GASTROENTEROLOGY, V144, P1303, DOI 10.1053/j.gastro.2013.01.073
   Jacobson BC, 2005, GASTROINTEST ENDOSC, V61, P363, DOI 10.1016/S0016-5107(04)02779-8
   Khalid A, 2007, AM J GASTROENTEROL, V102, P2339, DOI 10.1111/j.1572-0241.2007.01516.x
   Klibansky DA, 2012, CLIN GASTROENTEROL H, V10, P555, DOI 10.1016/j.cgh.2011.12.029
   Megibow AJ, 2011, RADIOL CLIN N AM, V49, P349, DOI 10.1016/j.rcl.2010.10.008
   Munigala S, 2016, GASTROINTEST ENDOSC, V84, P81, DOI 10.1016/j.gie.2015.10.030
   Nagai K, 2009, J HEPATO-BILIARY-PAN, V16, P353, DOI 10.1007/s00534-009-0068-8
   Pelaez-Luna M, 2007, AM J GASTROENTEROL, V102, P1759, DOI 10.1111/j.1572-0241.2007.01224.x
   Scheiman JM, 2015, GASTROENTEROLOGY, V148, P824, DOI 10.1053/j.gastro.2015.01.014
   Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023
   Tanaka M, 2017, PANCREATOLOGY, V17, P738, DOI 10.1016/j.pan.2017.07.007
   Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004
   Tang RS, 2008, CLIN GASTROENTEROL H, V6, P815, DOI 10.1016/j.cgh.2008.04.005
NR 15
TC 0
Z9 0
U1 0
U2 0
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 8226 REGENCY DR, PLEASANTON, CA 94588 USA
SN 2307-8960
J9 WORLD J CLIN CASES
JI World J. Clin. Cases
PD NOV 6
PY 2018
VL 6
IS 13
BP 624
EP 631
DI 10.12998/wjcc.v6.i13.624
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA GZ6HZ
UT WOS:000449537400005
PM 30430117
OA Green Published, Other Gold
DA 2020-11-30
ER

PT J
AU Pan, DZ
   Garske, K
   Ko, A
   Bagat, Y
   Alvarez, M
   Raulerson, CK
   Sinsheimer, J
   Mohlke, KL
   Laakso, M
   Pajukanta, P
AF Pan, D. Z.
   Garske, K.
   Ko, A.
   Bagat, Y.
   Alvarez, M.
   Raulerson, C. K.
   Sinsheimer, J.
   Mohlke, K. L.
   Laakso, M.
   Pajukanta, P.
TI Adipose cis-eQTL variants at enhancer-promoter interaction circuits
   regulate obesity genes
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Meeting Abstract
CT 50th European-Society-of-Human-Genetics (ESHG) Conference
CY MAY 27-30, 2017
CL Copenhagen, DENMARK
SP European Soc Human Genet
C1 [Pan, D. Z.; Garske, K.; Ko, A.; Bagat, Y.; Alvarez, M.; Sinsheimer, J.; Pajukanta, P.] Univ Calif Los Angeles, Los Angeles, CA USA.
   [Raulerson, C. K.; Mohlke, K. L.] Univ N Carolina, Chapel Hill, NC 27515 USA.
   [Laakso, M.] Univ Eastern Finland, Kuopio, Finland.
   [Laakso, M.] Kuopio Univ Hosp, Kuopio, Finland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD OCT
PY 2018
VL 26
SU S
MA C22.4
BP 108
EP 108
PG 1
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA JC5HS
UT WOS:000489312600197
DA 2020-11-30
ER

PT J
AU Ko, A
   Kaminska, D
   Nikkola, E
   Pihlajamaki, J
   Pajukanta, P
AF Ko, A.
   Kaminska, D.
   Nikkola, E.
   Pihlajamaki, J.
   Pajukanta, P.
TI Human liver transcriptomes reveal tight co-regulation of cholesterol
   synthesis pathway and DERL3 as a potential liver cancer driver
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Meeting Abstract
CT 50th European-Society-of-Human-Genetics (ESHG) Conference
CY MAY 27-30, 2017
CL Copenhagen, DENMARK
SP European Soc Human Genet
C1 [Ko, A.; Kaminska, D.; Nikkola, E.; Pajukanta, P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.
   [Ko, A.; Pajukanta, P.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA.
   [Pihlajamaki, J.] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland.
   [Pihlajamaki, J.] Kuopio Univ Hosp, Clin Nutr & Obes Ctr, Kuopio, Finland.
   [Pajukanta, P.] Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD OCT
PY 2018
VL 26
SU S
MA P03.30B
BP 210
EP 211
PG 2
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA JC5HS
UT WOS:000489312601188
DA 2020-11-30
ER

PT J
AU Ko, A
   Li, MS
   Reeder, G
   Lu, K
AF Ko, A.
   Li, M. S.
   Reeder, G.
   Lu, K.
TI ECONOMIC BURDEN OF ERYTHROPOIESIS STIMULATING AGENT (ESA) TO THE
   MEDICARE SYSTEM POST PART D
SO VALUE IN HEALTH
LA English
DT Meeting Abstract
C1 [Ko, A.; Lu, K.] Univ South Carolina, Coll Pharm, Columbia, SC USA.
   [Li, M. S.] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA.
   [Reeder, G.] Univ South Carolina, Kennedy Pharm Innovat Ctr, Columbia, SC USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1098-3015
EI 1524-4733
J9 VALUE HEALTH
JI Value Health
PD SEP
PY 2018
VL 21
SU 2
MA PSY8
BP S107
EP S108
DI 10.1016/j.jval.2018.07.824
PG 2
WC Economics; Health Care Sciences & Services; Health Policy & Services
SC Business & Economics; Health Care Sciences & Services
GA HL4MZ
UT WOS:000458697200593
OA Bronze
DA 2020-11-30
ER

PT J
AU Ko, A
   Venkatesan, N
   Chatoff, J
   Morselli, M
   Fishbein, G
   Bomont, P
   Pellegrini, M
   Wang, M
   Srivatsan, E
AF Ko, Albert
   Venkatesan, Natarajan
   Chatoff, Jenna
   Morselli, Marco
   Fishbein, Gregory
   Bomont, Pascale
   Pellegrini, Matteo
   Wang, Marilene
   Srivatsan, Eri
TI GAN gene exon 8 SNP is related to gigaxonin expression and increased
   expression of e-cadherin in head and neck cancer
SO CANCER RESEARCH
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-for-Cancer-Research (AACR)
CY APR 14-18, 2018
CL Chicago, IL
SP Amer Assoc Canc Res
C1 [Ko, Albert; Morselli, Marco; Fishbein, Gregory; Pellegrini, Matteo; Wang, Marilene] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Venkatesan, Natarajan; Chatoff, Jenna; Srivatsan, Eri] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA.
   [Bomont, Pascale] Inst Neurosci Montpellier, Montpellier, France.
RI Bomont, Pascale L/Y-5517-2018; Morselli, Marco/AAF-3182-2019
OI Bomont, Pascale L/0000-0001-7216-3261; Morselli,
   Marco/0000-0003-3351-5791
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
EI 1538-7445
J9 CANCER RES
JI Cancer Res.
PD JUL
PY 2018
VL 78
IS 13
SU S
MA 5505
DI 10.1158/1538-7445.AM2018-5505
PG 1
WC Oncology
SC Oncology
GA HZ4LO
UT WOS:000468819504487
DA 2020-11-30
ER

PT J
AU Lim, B
   Girgis, A
   Alonso, E
   Nguyen, A
   Tekeste, T
   Chang, K
   Adeyemo, M
   Eskandari, A
   Yaramada, P
   Chaya, C
   Burke, E
   Ko, A
   Butler, R
   Kawatkar, A
   Roggow, I
AF Lim, Brian
   Girgis, Agathon
   Alonso, Emilio
   Nguyen, Andrew
   Tekeste, Timnit
   Chang, Karen
   Adeyemo, Mopelola
   Eskandari, Armen
   Yaramada, Priya
   Chaya, Charles
   Burke, Edmund
   Ko, Albert
   Butler, Rebecca
   Kawatkar, Aniket
   Roggow, Isaiah
TI Update on the Effect of Region-Wide Incorporation of an Algorithm Based
   on 2012 International Consensus Guideline on the Practice Pattern for
   the Management of Pancreatic Cystic Neoplasms in an Integrated Health
   System
SO AMERICAN JOURNAL OF GASTROENTEROLOGY
LA English
DT Meeting Abstract
CT 82nd Annual Scientific Meeting of the
   American-College-of-Gastroenterology (ACG)
CY OCT 13-18, 2017
CL Orlando, FL
SP Amer Coll Gastroenterol
C1 [Lim, Brian] UC Riverside Sch Med, Kaiser Permanente Riverside Med Ctr, Riverside, CA USA.
   [Girgis, Agathon; Alonso, Emilio; Tekeste, Timnit; Chang, Karen; Adeyemo, Mopelola; Roggow, Isaiah] UC Riverside Sch Med, Riverside, CA USA.
   [Nguyen, Andrew] Univ Calif Riverside, Sch Med, Moreno Valley, CA USA.
   [Eskandari, Armen] UC Davis Med Ctr, Sacramento, CA USA.
   [Yaramada, Priya; Burke, Edmund; Ko, Albert] Kaiser Permanente Riverside Med Ctr, Riverside, CA USA.
   [Chaya, Charles] Kaiser Permanente Riverside Med Ctr, Riverside, AR USA.
   [Butler, Rebecca] Kaiser Permanente Southern Calif, Dept Res & Evaluat, Pasadena, CA USA.
   [Kawatkar, Aniket] Kaiser Permanente Southern Calif, Pasadena, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0002-9270
EI 1572-0241
J9 AM J GASTROENTEROL
JI Am. J. Gastroenterol.
PD OCT
PY 2017
VL 112
SU S
MA 59
BP S27
EP S27
DI 10.14309/00000434-201710001-00059
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA GN6ZP
UT WOS:000439259000060
DA 2020-11-30
ER

PT J
AU Lim, B
   Girgis, A
   Alonso, E
   Yaramada, P
   Burke, E
   Eskandari, A
   Roggow, I
   Chaya, C
   Nguyen, A
   Ko, AX
AF Lim, Brian
   Girgis, Agathon
   Alonso, Emilio
   Yaramada, Priya
   Burke, Edmund
   Eskandari, Armen
   Roggow, Isaiah
   Chaya, Charles
   Nguyen, Andrew
   Ko, Albert X.
TI The Effect of Region-Wide Incorporation of an Algorithm Based on the
   2012 International Consensus Guideline on the Practice Pattern for the
   Management of Pancreatic Cystic Neoplasms in an Integrated Health System
SO AMERICAN JOURNAL OF GASTROENTEROLOGY
LA English
DT Meeting Abstract
CT 81st Annual Scientific Meeting of the
   American-College-of-Gastroenterology
CY OCT 21-26, 2016
CL Las Vegas, NV
SP Amer Coll Gastroenterol
C1 [Lim, Brian] Univ Calif Riverside, Irvine, CA USA.
   [Girgis, Agathon; Alonso, Emilio; Yaramada, Priya; Roggow, Isaiah; Nguyen, Andrew] Univ Calif Riverside, Sch Med, Riverside, CA 92521 USA.
   [Burke, Edmund; Chaya, Charles] Kaiser Permanente Riverside Med Ctr, Riverside, CA USA.
   [Eskandari, Armen] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA.
   [Ko, Albert X.] Univ Calif Riverside, Sch Med, Kaiser Riverside Med Ctr, Riverside, CA 92521 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0002-9270
EI 1572-0241
J9 AM J GASTROENTEROL
JI Am. J. Gastroenterol.
PD OCT
PY 2016
VL 111
SU 1
MA 99
BP S46
EP S46
DI 10.14309/00000434-201610001-00099
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA EN1IV
UT WOS:000395764600097
DA 2020-11-30
ER

PT J
AU Thomas, M
   Aix, SP
   Ko, A
   Jotte, R
   Ong, TJ
   Page, R
   Socinski, M
   Trunova, N
   Villaflor, V
   Spigel, DR
AF Thomas, M.
   Aix, S. Ponce
   Ko, A.
   Jotte, R.
   Ong, T. J.
   Page, R.
   Socinski, M.
   Trunova, N.
   Villaflor, V.
   Spigel, D. R.
TI nab-paclitaxel (nab-P) plus carboplatin (C) induction therapy in
   patients (Pts) with squamous (SCC) NSCLC: Interim quality of life (QoL)
   outcomes from the phase 3 ABOUND. sqm study
SO ANNALS OF ONCOLOGY
LA English
DT Meeting Abstract
C1 [Thomas, M.] German Ctr Lung Res DZL, Translat Lung Res Ctr Heidelberg, Univ Klinikum Heidelberg, Oncol,Internist Onkol Thoraxtumoren,Thoraxklin, Heidelberg, Germany.
   [Aix, S. Ponce] Unidad Invest Clin Canc Pulmon H12O CNIO, Oncol, Madrid, Spain.
   [Ko, A.] Celgene Corp, Biostats, Summit, NJ USA.
   [Jotte, R.] Rocky Mt Canc Ctr US Oncol Network, Oncol, Denver, CO USA.
   [Ong, T. J.] Celgene Corp, Med Affairs, Summit, NJ USA.
   [Page, R.] Ctr Canc & Blood Disorders, Oncol, Ft Worth, TX USA.
   [Socinski, M.] Univ Pittsburgh, Med Oncol, UPMC Canc Pavil, Pittsburgh, PA USA.
   [Trunova, N.] Celgene Corp, Med Affairs, Summit, NJ USA.
   [Villaflor, V.] Univ Chicago Med, Oncol, Chicago, IL USA.
   [Spigel, D. R.] Sarah Cannon Res Inst, Oncol, Nashville, TN USA.
FU Celgen Pharmaceutical
FX Celgen Pharmaceutical
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0923-7534
EI 1569-8041
J9 ANN ONCOL
JI Ann. Oncol.
PD OCT 1
PY 2016
VL 27
SU 6
MA 1279P
DI 10.1093/annonc/mdw383.79
PG 1
WC Oncology
SC Oncology
GA EK4QX
UT WOS:000393913000371
OA Bronze
DA 2020-11-30
ER

PT J
AU Hwang, M
   Park, J
   Ko, A
   Kho, Y
   Hwang, I
AF Hwang, M.
   Park, J.
   Ko, A.
   Kho, Y.
   Hwang, I.
TI The association with human biomonitoring and the sources of cadmium
   exposure among the general Korean adults
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 52nd Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 04-07, 2016
CL Seville, SPAIN
SP European Soc Toxicol
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD SEP 16
PY 2016
VL 258
SU S
MA P12-005
BP S206
EP S206
DI 10.1016/j.toxlet.2016.06.1751
PG 1
WC Toxicology
SC Toxicology
GA EW3XN
UT WOS:000402436700617
DA 2020-11-30
ER

PT J
AU Waterhouse, D
   Gutierrez, M
   Bekaii-Saab, T
   DeRosa, W
   Wainberg, Z
   George, B
   Fraser, CD
   Ko, A
   Pierce, DW
   Stergiopoulos, S
   Soliman, H
AF Waterhouse, D.
   Gutierrez, M.
   Bekaii-Saab, T.
   DeRosa, W.
   Wainberg, Z.
   George, B.
   Fraser, C. Duval
   Ko, A.
   Pierce, D. W.
   Stergiopoulos, S.
   Soliman, H.
TI nab-paclitaxel (nab-P) plus nivolumab (Nivo) in human epidermal growth
   factor receptor 2 (HER2)-negative recurrent metastatic breast cancer
   (MBC)
SO CANCER RESEARCH
LA English
DT Meeting Abstract
CT 38th Annual CTRC-AACR San Antonio Breast Cancer Symposium
CY DEC 08-12, 2015
CL San Antonio, TX
SP Canc Therapy Res Ctr, Amer Assoc Canc Res
C1 Oncol Hematol Care Inc, Cincinnati, OH USA.
   John Theurer Canc Ctr, Hackensack, NJ USA.
   Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA.
   Reg Canc Care Associates LLC, Morristown, NJ USA.
   UCLA Hematol Oncol, Santa Monica, CA USA.
   Med Coll Wisconsin, Milwaukee, WI 53226 USA.
   Celgene Corp, Summit, NJ USA.
   Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
EI 1538-7445
J9 CANCER RES
JI Cancer Res.
PD FEB 15
PY 2016
VL 76
SU 4
MA OT1-01-07
DI 10.1158/1538-7445.SABCS15-OT1-01-07
PG 2
WC Oncology
SC Oncology
GA DL4QN
UT WOS:000375622401308
DA 2020-11-30
ER

PT J
AU Eskandari, A
   Alonso, E
   Ko, A
   Lim, B
AF Eskandari, A.
   Alonso, E.
   Ko, A.
   Lim, B.
TI The Effect of an Integrated Health System Algorithm Based on 2012
   International Consensus Guideline on the Local Practice Pattern for the
   Management of Pancreatic Cystic Neoplasms
SO PANCREAS
LA English
DT Meeting Abstract
C1 [Eskandari, A.; Alonso, E.; Ko, A.; Lim, B.] Univ Calif Riverside, Sch Med, Riverside, CA 92521 USA.
   [Lim, B.] Kaiser Permanente Riverside Med Ctr, Dept Gastroenterol, Riverside, CA USA.
   [Ko, A.] Kaiser Permanente Riverside Med Ctr, Dept Surg, Riverside, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0885-3177
EI 1536-4828
J9 PANCREAS
JI Pancreas
PD NOV
PY 2015
VL 44
IS 8
BP 1372
EP 1372
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA CU2AQ
UT WOS:000363324000086
DA 2020-11-30
ER

PT J
AU Chaya, C
   Yaramada, P
   Ko, A
   Taira, M
   Tongson-Ignacio, J
   Lim, B
AF Chaya, Charles
   Yaramada, Priyanka
   Ko, Albert
   Taira, Mark
   Tongson-Ignacio, Jane
   Lim, Brian
TI Neoadjuvant Imatinib for Gastrointestinal Stromal Tumor (GIST):
   Community Hospital Experience
SO AMERICAN JOURNAL OF GASTROENTEROLOGY
LA English
DT Meeting Abstract
CT 79th Annual Scientific Meeting of the
   American-College-of-Gastroenterology
CY OCT 17-22, 2014
CL Philadelphia, PA
SP Amer Coll Gastroenterol
C1 [Chaya, Charles; Ko, Albert; Taira, Mark; Tongson-Ignacio, Jane; Lim, Brian] Kaiser Permanente, Riverside Med Ctr, Riverside, CA USA.
   [Yaramada, Priyanka] UC Riverside, Sch Med, Riverside, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0002-9270
EI 1572-0241
J9 AM J GASTROENTEROL
JI Am. J. Gastroenterol.
PD OCT
PY 2014
VL 109
SU 2
MA 192
BP S58
EP S58
DI 10.14309/00000434-201410002-00192
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA AS6OR
UT WOS:000344383100193
DA 2020-11-30
ER

PT J
AU Lim, B
   Thomas, S
   Rudek, R
   Chaya, C
   Pindur, A
   Phan, E
   Ko, A
   Lawrence, M
   Wen, R
   Ma, J
AF Lim, Brian
   Thomas, Sarah
   Rudek, Robert
   Chaya, Charles
   Pindur, Ales
   Phan, Emily
   Ko, Albert
   Lawrence, Michael
   Wen, Robert
   Ma, James
TI Idiopathic Ileocolonic Varices: Combined GI-Surgery Approach for
   Management of a Rare Condition
SO AMERICAN JOURNAL OF GASTROENTEROLOGY
LA English
DT Meeting Abstract
CT 79th Annual Scientific Meeting of the
   American-College-of-Gastroenterology
CY OCT 17-22, 2014
CL Philadelphia, PA
SP Amer Coll Gastroenterol
C1 [Lim, Brian; Rudek, Robert; Chaya, Charles; Pindur, Ales; Phan, Emily; Ko, Albert; Lawrence, Michael; Wen, Robert; Ma, James] Kaiser Permanente Riverside Med Ctr, Riverside, CA USA.
   [Thomas, Sarah] UC Riverside, Sch Med, Riverside, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0002-9270
EI 1572-0241
J9 AM J GASTROENTEROL
JI Am. J. Gastroenterol.
PD OCT
PY 2014
VL 109
SU 2
MA 2165
BP S628
EP S628
DI 10.14309/00000434-201410002-02165
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA AS6OR
UT WOS:000344383102520
DA 2020-11-30
ER

PT J
AU Patt, D
   Liang, C
   Li, L
   Ko, A
   Fraser, CD
   Corzo, D
   Enger, C
AF Patt, D.
   Liang, C.
   Li, L.
   Ko, A.
   Fraser, Duval C.
   Corzo, D.
   Enger, C.
TI REAL-WORLD SAFETY AND EFICACY OF NAB-PACLITAXEL IN PATIENTS WITH
   METASTATIC BREAST CANCER (MBC) TREATED IN THE UNITED STATES: RESULTS
   FROM A HEALTH INSURANCE DATABASE
SO VALUE IN HEALTH
LA English
DT Meeting Abstract
C1 [Patt, D.] McKesson Specialty Hlth MSH US Oncol USO, Austin, TX USA.
   [Liang, C.; Li, L.] Optum, Waltham, MA USA.
   [Ko, A.; Fraser, Duval C.] Celgene Corp, Berkeley Hts, NJ USA.
   [Corzo, D.] Celgene Corp, Summit, NJ USA.
   [Enger, C.] Optum, Ann Arbor, MI USA.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1098-3015
EI 1524-4733
J9 VALUE HEALTH
JI Value Health
PD MAY
PY 2014
VL 17
IS 3
MA PCN18
BP A70
EP A71
DI 10.1016/j.jval.2014.03.413
PG 2
WC Economics; Health Care Sciences & Services; Health Policy & Services
SC Business & Economics; Health Care Sciences & Services
GA AO1OG
UT WOS:000341082000383
OA Bronze
DA 2020-11-30
ER

PT J
AU Chaya, C
   Lim, B
   Ko, A
AF Chaya, Charles
   Lim, Brian
   Ko, Albert
TI Application of Guidelines to Suspected Mucinous-Type Pancreatic Cysts
   with Unhelpful CEA Values
SO AMERICAN JOURNAL OF GASTROENTEROLOGY
LA English
DT Meeting Abstract
CT 78th Annual Scientific Meeting of the
   American-College-of-Gastroenterology
CY OCT 11-16, 2013
CL San Diego, CA
SP Amer Coll Gastroenterol
C1 [Chaya, Charles; Lim, Brian; Ko, Albert] Kaiser Riverside, Riverside, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0002-9270
EI 1572-0241
J9 AM J GASTROENTEROL
JI Am. J. Gastroenterol.
PD OCT
PY 2013
VL 108
SU 1
MA 298
BP S90
EP S90
DI 10.14309/00000434-201310001-00298
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 296II
UT WOS:000330178100299
DA 2020-11-30
ER

PT J
AU Goldstein, D
   Von Hoff, DD
   Moore, M
   Greeno, E
   Ritch, P
   Tortora, G
   Ramanathan, RK
   Tabernero, J
   Ko, A
   Lu, B
AF Goldstein, D.
   Von Hoff, D. D.
   Moore, M.
   Greeno, E.
   Ritch, P.
   Tortora, G.
   Ramanathan, R. K.
   Tabernero, J.
   Ko, A.
   Lu, B.
TI Evaluation of peripheral neuropathy in a phase Ill trial (MPACT) of
   weekly nab-paclitaxel (nab-P) plus gemcitabine (G) vs G alone for
   patients with metastatic adenocarcinoma of the pancreas
SO EUROPEAN JOURNAL OF CANCER
LA English
DT Meeting Abstract
CT European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO
CY SEP 27-OCT 01, 2013
CL Amsterdam, NETHERLANDS
SP European Conf Clin Oncol, European Soc Therapeut Radiol & Oncol, European Soc Med Oncol, European Soc Surg Oncol, European Assoc Canc Res, European Oncol Nursing Soc, European Soc Paediat Oncol
C1 [Goldstein, D.] Prince Wales Hosp, Sydney, NSW, Australia.
   [Von Hoff, D. D.; Ramanathan, R. K.] Scottsdale Healthcare TGen, Scottsdale, AZ USA.
   [Moore, M.] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada.
   [Greeno, E.] Univ Minnesota, Minneapolis, MN USA.
   [Ritch, P.] Med Coll Wisconsin, Milwaukee, WI 53226 USA.
   [Tortora, G.] Azienda Osped Univ Integrata Verona, Verona, Italy.
   [Tabernero, J.] Vall Hebron Univ Hosp, Barcelona, Spain.
   [Ko, A.; Lu, B.] Celgene Corp, Summit, NJ USA.
RI Tabernero, Josep/AAG-5026-2019; Tortora, Giampaolo/AAA-1252-2019
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0959-8049
EI 1879-0852
J9 EUR J CANCER
JI Eur. J. Cancer
PD SEP
PY 2013
VL 49
SU 2
MA 2583
BP S613
EP S613
PG 1
WC Oncology
SC Oncology
GA 250HY
UT WOS:000326843604021
DA 2020-11-30
ER

PT J
AU Testori, A
   Hersh, EM
   Del Vecchio, M
   Brown, MP
   Clements, A
   Loquai, C
   Robert, C
   Ko, A
   Elias, I
   Hauschild, A
AF Testori, A.
   Hersh, E. M.
   Del Vecchio, M.
   Brown, M. P.
   Clements, A.
   Loquai, C.
   Robert, C.
   Ko, A.
   Elias, I.
   Hauschild, A.
TI A phase III trial of nab-paclitaxel vs dacarbazine in chemotherapy-naive
   patients with metastatic melanoma: Analysis of patients with M1c stage
   disease
SO EUROPEAN JOURNAL OF CANCER
LA English
DT Meeting Abstract
CT European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO
CY SEP 27-OCT 01, 2013
CL Amsterdam, NETHERLANDS
SP European Conf Clin Oncol, European Soc Therapeut Radiol & Oncol, European Soc Med Oncol, European Soc Surg Oncol, European Assoc Canc Res, European Oncol Nursing Soc, European Soc Paediat Oncol
C1 [Testori, A.] European Inst Oncol, Milan, Italy.
   [Hersh, E. M.] Univ Arizona, Ctr Canc, Tucson, AZ USA.
   [Del Vecchio, M.] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy.
   [Brown, M. P.] Royal Adelaide Hosp, Adelaide, SA 5000, Australia.
   [Clements, A.] Westmead Hosp, Westmead, NSW 2145, Australia.
   [Clements, A.] Melanoma Inst Australia, Westmead, NSW, Australia.
   [Loquai, C.] Johannes Gutenberg Univ Mainz, Univ Med, D-55122 Mainz, Germany.
   [Robert, C.] Inst Gustave Roussy, Villejuif, Fiji.
   [Ko, A.] Celgene Corp, Summit, NJ USA.
   [Elias, I.] Celgene, Toronto, ON, Canada.
   [Hauschild, A.] Univ Klinikum Schleswig Holstein, Kiel, Germany.
RI Loquai, Carmen/AAW-9241-2020
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0959-8049
EI 1879-0852
J9 EUR J CANCER
JI Eur. J. Cancer
PD SEP
PY 2013
VL 49
SU 2
MA 3737
BP S867
EP S867
PG 1
WC Oncology
SC Oncology
GA 250HY
UT WOS:000326843605345
DA 2020-11-30
ER

PT J
AU Lim, B
   Ko, A
   Chaya, C
AF Lim, Brian
   Ko, Albert
   Chaya, Charles
TI Punched Pancreatic Tumor: A Case of Trauma-induced Hematoma of
   Pancreatic Pseudopapillary Tumor
SO AMERICAN JOURNAL OF GASTROENTEROLOGY
LA English
DT Meeting Abstract
C1 [Lim, Brian; Ko, Albert; Chaya, Charles] Kaiser Permanente Riverside Med Ctr, Corona, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0002-9270
EI 1572-0241
J9 AM J GASTROENTEROL
JI Am. J. Gastroenterol.
PD OCT
PY 2012
VL 107
SU 1
MA 833
BP S343
EP S343
DI 10.14309/00000434-201210001-00833
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA V30UA
UT WOS:000208839701271
DA 2020-11-30
ER

PT J
AU Lim, B
   Chaya, C
   Burke, E
   Ko, A
AF Lim, Brian
   Chaya, Charles
   Burke, Edmund
   Ko, Albert
TI Diagnostic Performance of Pancreatic Cyst Fluid Carcinoembryonic Antigen
   (CEA) and Amylase: A Community Hospital Experience
SO AMERICAN JOURNAL OF GASTROENTEROLOGY
LA English
DT Meeting Abstract
C1 [Lim, Brian; Chaya, Charles; Burke, Edmund; Ko, Albert] Kaiser Permanente Riverside Med Ctr, Riverside, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0002-9270
EI 1572-0241
J9 AM J GASTROENTEROL
JI Am. J. Gastroenterol.
PD OCT
PY 2012
VL 107
SU 1
MA 209
BP S90
EP S90
DI 10.14309/00000434-201210001-00209
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA V30UA
UT WOS:000208839700210
DA 2020-11-30
ER

PT J
AU Delmas, PD
   Gineyts, E
   Mo, J
   Ko, A
   Henriksen, DB
   Curtis, SP
   Gertz, BJ
AF Delmas, PD
   Gineyts, E
   Mo, J
   Ko, A
   Henriksen, DB
   Curtis, SP
   Gertz, BJ
TI Effects of ibuprofen on type II collagen C-telopeptide (uCTX-II) levels,
   a marker of cartilage degradation, in patients with osteoarthritis (OA)
   of the knee.
SO ARTHRITIS AND RHEUMATISM
LA English
DT Meeting Abstract
NR 0
TC 3
Z9 3
U1 0
U2 0
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0004-3591
J9 ARTHRITIS RHEUM
JI Arthritis Rheum.
PD SEP
PY 2001
VL 44
IS 9
SU S
MA 521
BP S139
EP S139
PG 1
WC Rheumatology
SC Rheumatology
GA 498EB
UT WOS:000172495900580
DA 2020-11-30
ER

PT J
AU Yang, RH
   Bunting, S
   Ko, A
   Keyt, BA
   Modi, NB
   Zioncheck, TF
   Ferrara, N
   Jin, HK
AF Yang, RH
   Bunting, S
   Ko, A
   Keyt, BA
   Modi, NB
   Zioncheck, TF
   Ferrara, N
   Jin, HK
TI Substantially attenuated hemodynamic responses to Escherichia
   coli-derived vascular endothelial growth factor given by intravenous
   infusion compared with bolus injection
SO JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
LA English
DT Article
ID PERMEABILITY FACTOR; CELL MITOGEN; THERAPEUTIC ANGIOGENESIS; BLOOD-FLOW;
   REVASCULARIZATION; IDENTIFICATION; SECRETE; LIMB
AB Vascular endothelial growth factor (VEGF) produces beneficial angiogenesis in animal models of coronary and peripheral ischemia. However, intravenous bolus injection of Chinese hamster ovary cell (CHO)-derived VEGF produces adverse effects on hemodynamics. The present study examined pharmacokinetic and hemodynamic responses to Escherichia coli-derived VEGF, which will be used in clinical patients, compared with responses to CHO-derived VEGF, and tested whether intravenous infusion of E. coli-derived VEGF attenuates the hemodynamic responses compared with the responses observed with intravenous bolus injection. Hemodynamic parameters were measured before and after administration of VEGF in conscious, instrumented rats. Intravenous injection of both CHO- and E. coli-derived VEGF produced a similar maximal reduction in arterial pressure, although E. coli-derived VEGF exhibited less of a depressor effect in the initial phase after injection. Either infusion or injection of E. coli-derived VEGF caused hypotension, tachycardia and reduced cardiac output and stroke volume, which were significantly attenuated when given by infusion compared with injection. The maximal hypotensive and tachycardic responses to infusion were decreased by 50 to 60% compared with those responses observed after injection. Cardiac output was maximally reduced by 34% after injection, but only 18% after infusion. A sustained elevation in systemic vascular resistance observed after injection was avoided after infusion. Thus, the hemodynamic side effects of VEGF administration can be substantially attenuated by controlling the rate of VEGF infusion. The data indicate that infusion, instead of bolus injection, is a more appropriate regimen for VEGF administration.
C1 Genentech Inc, Dept Cardiovasc Res, San Francisco, CA 94080 USA.
   Genentech Inc, Dept Metab & Pharmacokinet, San Francisco, CA 94080 USA.
RP Jin, HK (corresponding author), Genentech Inc, Dept Cardiovasc Res, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA.
OI Modi, Nishit/0000-0002-5111-867X
CR BANAI S, 1994, CIRCULATION, V89, P2183, DOI 10.1161/01.CIR.89.5.2183
   BAUTERS C, 1995, J VASC SURG, V21, P314, DOI 10.1016/S0741-5214(95)70272-5
   CLAFFEY KP, 1995, BBA-PROTEIN STRUCT M, V1246, P1, DOI 10.1016/0167-4838(94)00144-6
   CONN G, 1990, P NATL ACAD SCI USA, V87, P2628, DOI 10.1073/pnas.87.7.2628
   CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322
   DEGUZMAN GG, 1997, AM ASS PHARM SCI M A
   FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8
   FERRARA N, 1991, METHOD ENZYMOL, V198, P391
   Gibaldi M, 1982, PHARMACOKINETICS
   Hariawala MD, 1996, J SURG RES, V63, P77, DOI 10.1006/jsre.1996.0226
   HOROWITZ J, 1995, CIRCULATION S1, V92, P630
   HOUCK KA, 1991, MOL ENDOCRINOL, V5, P1806, DOI 10.1210/mend-5-12-1806
   KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987
   Keyt BA, 1996, J BIOL CHEM, V271, P5638, DOI 10.1074/jbc.271.10.5638
   Kim KJ, 1992, GROWTH FACTORS, V7, P53, DOI 10.3109/08977199209023937
   LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986
   NICOSIA RF, 1994, AM J PATHOL, V145, P1023
   PEARLMAN JD, 1995, NAT MED, V1, P1085, DOI 10.1038/nm1095-1085
   PEPPER MS, 1992, BIOCHEM BIOPH RES CO, V189, P824, DOI 10.1016/0006-291X(92)92277-5
   Phillips G D, 1994, In Vivo, V8, P961
   PLOUET J, 1989, EMBO J, V8, P3801, DOI 10.1002/j.1460-2075.1989.tb08557.x
   PU LQ, 1993, CIRCULATION, V88, P208, DOI 10.1161/01.CIR.88.1.208
   SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562
   SENGER DR, 1986, CANCER RES, V46, P5629
   TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018
   TISCHER E, 1991, J BIOL CHEM, V266, P11947
   Tolentino MJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P964, DOI 10.1001/archopht.1996.01100140172010
   Walter DH, 1996, LAB INVEST, V74, P546
   Yang RH, 1996, J CARDIOVASC PHARM, V27, P838, DOI 10.1097/00005344-199606000-00011
NR 29
TC 43
Z9 45
U1 0
U2 2
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0022-3565
EI 1521-0103
J9 J PHARMACOL EXP THER
JI J. Pharmacol. Exp. Ther.
PD JAN
PY 1998
VL 284
IS 1
BP 103
EP 110
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA YQ672
UT WOS:000071411700015
PM 9435167
DA 2020-11-30
ER

PT J
AU Yang, RH
   Bunting, S
   Ko, A
   Schwall, R
   Jin, HK
AF Yang, RH
   Bunting, S
   Ko, A
   Schwall, R
   Jin, HK
TI Hemodynamic effects of scatter factor in conscious rats
SO JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
LA English
DT Article
DE scatter factor; hepatocyte growth factor; vascular endothelial growth
   factor; hemodynamic; cardiac function; cardiac output
ID HEPATOCYTE GROWTH-FACTOR; VASCULAR-PERMEABILITY FACTOR; MICROVASCULAR
   ENDOTHELIAL-CELLS; THERAPEUTIC ANGIOGENESIS; CARDIAC-PERFORMANCE;
   HEART-FAILURE; MITOGEN; MET; MIGRATION; VARIANT
AB Scatter factor (SF), also known as hepatocyte growth factor, is a potent mitogen that has been suggested to exhibit greater efficacy than vascular endothelial growth factor (VEGF) in rabbits with hindlimb ischemia. Our study examined the effects of SF on cardiovascular hemodynamics and compared the responses to VEGF. Hemodynamic parameters were monitored before and after administration of SF or VEGF in conscious, instrumented rats. Intravenous injection of SF-produced a dose-related reduction in mean arterial pressure (MAP) and increase in heart rate (HR). These responses were significantly attenuated by pretreatment with N-omega-nitro-L-arginine methyl ester, a nitric oxide (NO) synthase inhibitor, suggesting the depressor effect of SF may be mediated by NO. SF (250 mu g/kg) reduced stroke volume and cardiac output, but did not affect the maximal first derivation of left ventricular pressure (dP/dt), suggesting that the reduction in cardiac output is caused by decreased stroke volume that probably results from a reduction in venous return. Compared with SF, VEGF produced greater hypotensive and tachycardic responses and greater reductions in stroke volume and cardiac output, indicating that SF has fewer side effects on hemodynamics. Although both growth factors might reduce venous return, SF decreased hematocrit presumably through venodilation, whereas VEGF increased hematocrit as a result of vascular hyperpermeability.
C1 GENENTECH INC, DEPT CARDIOVASC RES, SAN FRANCISCO, CA 94080 USA.
   GENENTECH INC, DEPT MOL BIOL, SAN FRANCISCO, CA 94080 USA.
CR BANAI S, 1994, CIRCULATION, V89, P2183, DOI 10.1161/01.CIR.89.5.2183
   BAUTERS C, 1995, J VASC SURG, V21, P314, DOI 10.1016/S0741-5214(95)70272-5
   BELLE EV, 1995, CIRCULATION, V92, P748
   BHARGAVA M, 1992, CELL GROWTH DIFFER, V3, P11
   BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629
   BUTTRICK P, 1991, AM J PHYSIOL, V260, pH473
   CHIEN YW, 1989, AM J PHYSIOL, V257, pR1481
   COMOGLIO PM, 1993, HEPATOCYTE GROWTH FA, P131
   CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322
   FERRARA N, 1991, METHOD ENZYMOL, V198, P391
   GHERARDI E, 1991, CANCER CELL-MON REV, V3, P227
   GRANT DS, 1993, P NATL ACAD SCI USA, V90, P1937, DOI 10.1073/pnas.90.5.1937
   HOROWITZ J, 1995, CIRCULATION S1, V92, P630
   KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987
   KU DD, 1993, AM J PHYSIOL, V265, pH585
   MORIMOTO A, 1991, BIOCHEM BIOPH RES CO, V179, P1042, DOI 10.1016/0006-291X(91)91924-2
   NALDINI L, 1991, EMBO J, V10, P2867, DOI 10.1002/j.1460-2075.1991.tb07836.x
   PEARLMAN JD, 1995, NAT MED, V1, P1085, DOI 10.1038/nm1095-1085
   PFEFFER JM, 1985, CIRC RES, V57, P84, DOI 10.1161/01.RES.57.1.84
   ROSEN EM, 1991, J CELL PHYSIOL, V146, P325, DOI 10.1002/jcp.1041460218
   Rosen EM, 1995, ADV CANCER RES, V67, P257, DOI 10.1016/S0065-230X(08)60715-0
   ROSEN EM, 1990, EXP CELL RES, V186, P22, DOI 10.1016/0014-4827(90)90205-O
   ROSEN EM, 1993, SYM SOC EXP BIOL, V47, P227
   RUBIN JS, 1991, P NATL ACAD SCI USA, V88, P415, DOI 10.1073/pnas.88.2.415
   SATO Y, 1993, EXP CELL RES, V204, P223, DOI 10.1006/excr.1993.1028
   SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562
   SENGER DR, 1986, CANCER RES, V46, P5629
   SHIMA N, 1994, BIOCHEM BIOPH RES CO, V200, P808, DOI 10.1006/bbrc.1994.1523
   SILVAGNO F, 1995, ARTERIOSCL THROM VAS, V15, P1857, DOI 10.1161/01.ATV.15.11.1857
   TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018
   WEIDNER KM, 1991, P NATL ACAD SCI USA, V88, P7001, DOI 10.1073/pnas.88.16.7001
   Yang RH, 1996, J CARDIOVASC PHARM, V27, P838, DOI 10.1097/00005344-199606000-00011
   YANG RH, 1995, CIRCULATION, V92, P262, DOI 10.1161/01.CIR.92.2.262
NR 33
TC 15
Z9 16
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0160-2446
EI 1533-4023
J9 J CARDIOVASC PHARM
JI J. Cardiovasc. Pharmacol.
PD SEP
PY 1997
VL 30
IS 3
BP 294
EP 301
DI 10.1097/00005344-199709000-00004
PG 8
WC Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy
SC Cardiovascular System & Cardiology; Pharmacology & Pharmacy
GA YK703
UT WOS:A1997YK70300004
PM 9300311
DA 2020-11-30
ER

EF